Healthtech CEO Strategy: Taking a 20-Disease Detection Technology to Market

You are the CEO of a health-tech startup that has built technology able to detect 20 deadly diseases. How would you approach turning it into a product and a business: where would you start, and how would you get it to patients? ```hint You cannot launch all 20 at once With limited money, people and time, the first decision is where to start. Think about what would make one disease, and one kind of customer, a much better first bet than another. ``` ### Clarifying Questions - What form does the technology take, such as a blood test, an imaging analysis or a wearable signal, and does it find these diseases earlier than today's methods or just more cheaply? - How accurate is it today for each of the 20 diseases, and has any of it been clinically validated or cleared by a regulator? - How much runway and how large a team does the company have, and are there existing customers or partners? - Which market should I assume for regulation and payment, for example the United States? ### What a Strong Answer Covers - A stated objective that balances patient impact with building a company that survives long enough to deliver it - Explicit criteria for choosing the first one or two diseases, applied to the 20 rather than only listed - A choice of first customer and channel, such as health systems, insurers, employers or consumers, with the reason - Accuracy, false positives and the follow-up care a positive result triggers, treated as product decisions - A phased plan with milestones, metrics and the main risks ### Follow-up Questions - An investor urges you to sell a test for all 20 diseases directly to consumers next quarter. How do you respond? - The technology is very accurate for some diseases but gives many false positives for others. What do you do with the weaker ones? - What evidence would an insurer need before paying for the test, and how would you produce it?